Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oral Valganciclovir Versus Valacyclovir

This study has been completed.
Roche Pharma AG
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: November 20, 2007
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):